amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine besylate and benazepril hydrochloride
Generic Name amlodipine besylate and benazepril hydrochloride
Labeler bluepoint laboratories
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

amlodipine besylate 5 mg/1, benazepril hydrochloride 40 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-135
Product ID 68001-135_facbe2e1-8ede-d7e4-e053-6394a90ae44f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078466
Listing Expiration 2026-12-31
Marketing Start 2015-07-16

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] decreased blood pressure [pe] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001135
Hyphenated Format 68001-135

Supplemental Identifiers

RxCUI
898342 898346 898350 898353 898356 898359
UNII
864V2Q084H N1SN99T69T

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Generic Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Application Number ANDA078466 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (68001-135-00)
source: ndc

Packages (1)

68001-135-00 100 CAPSULE in 1 BOTTLE (68001-135-00)

Ingredients (2)

amlodipine besylate (5 mg/1) benazepril hydrochloride (40 mg/1)

Linked Drug Pages (1)

Amlodipine Besylate and Benazepril Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "facbe2e1-8ede-d7e4-e053-6394a90ae44f", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_set_id": ["df8e23c8-6c8f-4293-8a37-5ad3d48dba94"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68001-135-00)", "package_ndc": "68001-135-00", "marketing_start_date": "20150716"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "68001-135_facbe2e1-8ede-d7e4-e053-6394a90ae44f", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68001-135", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20150716", "listing_expiration_date": "20261231"}